Related Experiment Videos
Physicochemical properties of iodixanol
1Research and Development, Nycomed Imaging AS Oslo, Norway.
Acta Radiologica. Supplementum
|January 1, 1995
Summary
Iodixanol (Visipaque) is a novel nonionic, dimeric contrast medium with lower osmolality and viscosity than monomers. Its formulation allows for isotonic solutions, enhancing safety and efficacy in intravascular applications.
Area of Science:
- Radiology and Imaging
- Medical Diagnostics
- Pharmacology
Background:
- Conventional monomeric radiopaque contrast media often exhibit high osmolality, potentially causing adverse effects.
- Nonionic contrast agents were developed to mitigate risks associated with ionic agents.
- There is a continuous need for improved contrast media with better safety profiles and physiological compatibility.
Purpose of the Study:
- To introduce iodixanol, a new nonionic dimeric contrast medium.
- To evaluate the physicochemical properties of iodixanol, including osmolality, viscosity, and hydrophilicity.
- To compare iodixanol with existing contrast agents like iohexol.
Main Methods:
- Characterization of iodixanol as a nonionic, dimeric roentgen contrast medium.
- Assessment of osmolality of iodixanol solutions at various concentrations.
- Measurement of viscosity and partition coefficients to determine hydrophilicity.
- Formulation adjustments using sodium and calcium salts to achieve isotonicity.
Main Results:
- Aqueous solutions of iodixanol exhibit lower osmolality compared to nonionic monomers.
- Iodixanol solutions can be rendered isotonic by adding sodium and calcium salts.
- The viscosity of iodixanol solutions is comparable to or less than iohexol (Omnipaque) 350 mg I/ml.
- Iodixanol demonstrates high hydrophilicity and good aqueous solubility due to its molecular structure.
Conclusions:
- Iodixanol offers an advantageous low osmolality profile, making it suitable for intravascular use.
- The dimeric structure contributes to improved physiological compatibility and isotonic formulation possibilities.
- Iodixanol represents a significant advancement in nonionic dimeric contrast media, potentially improving patient safety.